Emami (531162) Q3 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 24/25 earnings summary
9 Jan, 2026Executive summary
Core domestic business grew 8.6%-9% in Q3 FY25 with 6% volume growth, marking the second consecutive quarter of high single-digit growth.
Consolidated Q3 revenue reached INR 1,049 crores (Rs 1,04,948 lacs), up 5% year-over-year, despite declines in male grooming and Kesh King segments.
BoroPlus and healthcare segments delivered strong growth, with BoroPlus up 20% and healthcare up 13%, led by Zandu Care.
Rebranding of Fair and Handsome to Smart and Handsome, with new product launches and a new brand ambassador, aims to broaden the male grooming portfolio.
Board declared a second interim dividend of 400% (INR 4/share), bringing the total FY25 payout to 800% (INR 8/share).
Financial highlights
Gross margin expanded by 150 bps to 70.3% in Q3; EBITDA grew 8% to INR 339 crores, with margin up 70 bps to 32.3%.
Profit after tax increased 8% to INR 279 crores in Q3; EPS for Q3 FY25 was Rs 6.39.
For nine months ended Dec 2024, gross margin rose 140 bps to 69.6%, EBITDA up 9% to INR 806 crores, and PAT up 12% to INR 644 crores.
Operating cash flow for nine months estimated at INR 500-550 crores.
Q3FY25 gross profit: ₹738 crore; EBITDA: ₹339 crore; PBT: ₹301 crore.
Outlook and guidance
Management expects continued double-digit growth in BoroPlus and healthcare in Q4, with positive momentum in core brands.
Anticipates robust growth ahead, supported by new launches, rebranding, and improving macroeconomic indicators.
Weighted average price increase of 1.5%-2% expected in the coming quarter.
Tax rate projected at 8%-9% for FY25 and around 10% for FY26.
Assam facility continues to benefit from income tax incentives until FY 2025-26.
Latest events from Emami
- Double-digit sales and profit growth, strong digital and rural segments, and interim dividend declared.531162
Q3 25/264 Feb 2026 - Flat revenue, higher margins, and strong pain management offset summer category declines.531162
Q1 25/263 Feb 2026 - Q1 FY25 delivered 10% revenue growth, margin expansion, and robust summer-led performance.531162
Q1 24/252 Feb 2026 - Q2 profit-led growth with margin expansion, new launches, and strong H2 outlook.531162
Q2 24/2515 Jan 2026 - FY25 delivered 6.5% revenue and 11% PAT growth, with strong brands and a special dividend.531162
Q4 24/2521 Nov 2025 - Q2 FY26 revenue fell 10% and profit dropped 29.7%, with a Rs. 4 interim dividend declared.531162
Q2 25/2610 Nov 2025